The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Company honored for creating an exceptional, people-first culture that empowers employees and fosters trust, transparency and authenticity

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received a Top Workplaces USA award for the third consecutive year. The national award program by Energage and USA Today celebrates organizations that have built exceptional workplace cultures. Castle was ranked 28th among 370 participating U.S. companies with 500-999 employees.

“I am so proud to accept this award once again on behalf of our exceptional employees, to whom I credit this honor,” said Derek Maetzold, president and chief executive officer at Castle Biosciences. “At Castle, our work to improve health through innovative tests that guide patient care is vitally important, but it’s the people — our valued Castle team members — who make Castle special. We have worked hard to create a work environment that truly supports our employees’ needs by providing an inclusive and welcoming atmosphere, competitive compensation packages, industry-leading benefits and a healthy work/life balance. The feedback we receive from our employees each year via this survey allows us to continually evaluate and improve upon our strong company culture.”

Top Workplace designations are garnered solely through anonymous employee feedback gathered through a third-party survey administered by Energage. The confidential survey measures 15 culture drivers that are indicative of successful organizations, such as alignment, execution and connection. Castle’s survey participation rate of 95% and employee engagement score of 86% were both above the benchmark averages of 61% and 75%, respectively, for other similar healthcare companies participating in the Top Workplaces program.

In addition to the 2024 Top Workplaces USA award, the Company has earned several past national and regional awards in this program, including:

  • Top Workplaces Industry, 2023 (Healthcare, ranking third out of 84 firms)
  • Top Workplaces Culture Excellence, 2023 and 2022 (Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, Purpose & Values, Employee Appreciation, Employee Well-Being, Professional Development)
  • Top Workplaces Houston, 2023, 2022 and 2021
  • Top Workplaces Arizona, 2023 and 2022

The comprehensive list of 2024 Top Workplaces USA can be found on USAToday.com.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

About Energage

Making the world a better place to work together.™

Energage is a purpose-driven technology company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 17 years of culture research and the results from 27 million employees surveyed across more than 70,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. For more information or to nominate your organization, visit energage.com or topworkplaces.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.